LL-37 vs KPV: Research Tracking Guide
LL-37 vs KPV
LL-37 and KPV are both research peptides studied for their antimicrobial and anti-inflammatory properties. Understanding their differences helps configure accurate research tracking in Dosed.
Important Disclaimer
LL-37 and KPV are research peptides NOT approved by the FDA for human use. They are sold for research and educational purposes only. Dosed tracking is for research documentation. This is not medical advice.
Comparison Table
Key Differences
- →Different peptide origins and sizes (37 vs 3 amino acids)
- →Different administration routes in research protocols
- →LL-37 is larger and more complex; KPV is a small tripeptide
- →Both studied for anti-inflammatory properties
- →Both are research compounds - not FDA approved
Tracking Considerations
- •Track administration route (oral vs injectable)
- •LL-37: Configure daily reminders, note if topical or subcutaneous
- •KPV: Track whether oral or injectable form
- •Document research observations with each administration
- •Research use only - maintain comprehensive documentation
Dosed App Features
- ✓Flexible scheduling for different protocols
- ✓Administration route tracking (oral/injectable/topical)
- ✓Daily reminder support
- ✓Reconstitution calculator for injectable forms
- ✓Research notes and observation logging
Quick Reference
- 💡Both are research peptides - not for human therapeutic use
- 💡KPV can be administered orally in some research protocols
- 💡LL-37 is a naturally occurring human peptide (cathelicidin)
- 💡See PMID citations for published research on each peptide
Track Your Protocol
Set up reminders, track your doses, and maintain your protocol history with Dosed.
Download DosedFAQs
Common questions about this comparison
LL-37 is a 37-amino-acid human cathelicidin antimicrobial peptide. It's naturally produced by the human body but is also available as a research compound. See PMID: 19422822 for more information.
Some research protocols use oral KPV. Dosed can track oral administration schedules. The app accommodates both oral and injectable tracking for research documentation purposes.
For topical protocols, use Dosed's daily tracking with notes to document application site and frequency. This differs from injectable tracking as site rotation is less critical.